RESCULA Side Effects

6417667-9 | Punctate Keratitis
on Oct 15, 2009 Male patient from JAPAN , 66 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Rescula (View Usage). Patient experienced the following unwanted or unexpected effects: punctate keratitis. Rescula dosage: 4 Drops Daily.

6204796-8 | Asthma
Patient was taking Rescula (View Usage). Patient had the following side effects: asthma (What is asthma?) on May 08, 2009 from JAPAN Additional patient health information: Female patient , 87 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Rescula dosage: Unk. During the same period patient was treated with PRORANON (Unk) (View Proranon Review and Proranon Label ), NORVASC (2.5 Mg/day) (View Norvasc Review and Norvasc Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ), MAGNESIUM OXIDE (0.6 G/day) (View Magnesium Oxide Review and Magnesium Oxide Label ), PRANLUKAST (900 Mg/day) (View Pranlukast Review and Pranlukast Label ).

6063916-9 | Abnormal Sensation In Eye, Corneal Disorder, Eye Irritation, Foreign Body Sensation In Eyes, Hyperaemia, Keratitis Herpetic
Adverse event was reported on Jan 20, 2009 by a Male patient taking Rescula (View Usage) (Dosage: 2 Drops) was diagnosed with open angle glaucoma and. Location: JAPAN , 64 years of age, After Rescula was administered, patient had the following side effects: abnormal sensation in eye, corneal disorder, eye irritation, foreign body sensation in eyes, hyperaemia, keratitis herpetic. During the same period patient was treated with BETOPTIC (2 Drops) (View Betoptic Review and Betoptic Label ).

6013502-1 | Abnormal Sensation In Eye, Corneal Disorder, Eye Irritation, Foreign Body Sensation In Eyes, Hyperaemia, Keratitis Herpetic
on Dec 09, 2008 Male patient from JAPAN , 64 years of age, was diagnosed with open angle glaucoma and was treated with Rescula (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal sensation in eye, corneal disorder, eye irritation, foreign body sensation in eyes, hyperaemia, keratitis herpetic. Rescula dosage: 2 Drops. During the same period patient was treated with BETOPTIC (2 Drops) (View Betoptic Review and Betoptic Label ).


5630003-0 | Cerebral Infarction, Hypoaesthesia Oral
on Feb 05, 2008 Male patient from JAPAN , 71 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Rescula (View Usage). Patient had the following side effects: cerebral infarction, hypoaesthesia oral. Rescula dosage: 2 Drops. During the same period patient was treated with ASPIRIN (100 Mg/d) (View Aspirin Review and Aspirin Label ), LIPITOR (10 Mg/d) (View Lipitor Review and Lipitor Label ), GLUCOBAY (300 Mg/d) (View Glucobay Review and Glucobay Label ).

5599556-5 | Cerebral Infarction, Hypoaesthesia Oral
Patient was taking Rescula (View Usage). After Rescula was administered, patient had the following side effects: cerebral infarction, hypoaesthesia oral on Jan 15, 2008 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Rescula dosage: 2 Drops. During the same period patient was treated with ASPIRIN (100 Mg/d) (View Aspirin Review and Aspirin Label ), LIPITOR (10 Mg/d) (View Lipitor Review and Lipitor Label ), GLUCOBAY (300 Mg/d) (View Glucobay Review and Glucobay Label ).

5572856-0 | Cerebral Infarction, Hypoaesthesia Oral
Adverse event was reported on Dec 18, 2007 by a Male patient taking Rescula (View Usage) (Dosage: Unk, Unk) was diagnosed with glaucoma (What is glaucoma?) and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: cerebral infarction, hypoaesthesia oral. During the same period patient was treated with ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), LIPITOR (10 Mg, Unk) (View Lipitor Review and Lipitor Label ), GLUCOBAY (300 Mg, Unk) (View Glucobay Review and Glucobay Label ).

5308099-5 | Conjunctival Disorder, Corneal Opacity, Corneal Operation, Hypopyon, Pemphigoid, Symblepharon, Ulcerative Keratitis
on Apr 16, 2007 Female patient from JAPAN , 75 years of age, was diagnosed with open angle glaucoma, punctate keratitis and was treated with Rescula (View Usage). Patient had the following side effects: conjunctival disorder, corneal opacity, corneal operation, hypopyon, pemphigoid, symblepharon, ulcerative keratitis. Rescula dosage: 4 Drops. During the same period patient was treated with SANPILO (8 Drops) (View Sanpilo Review and Sanpilo Label ), PIVALEPHRINE (8 Drops) (View Pivalephrine Review and Pivalephrine Label ), BETOPTIC (4 Drops) (View Betoptic Review and Betoptic Label ), HYALEIN (16 Drops) (View Hyalein Review and Hyalein Label ). Patient was hospitalized and became disabled.

5306458-8 | Hypopyon, Pemphigoid, Symblepharon, Ulcerative Keratitis
on Apr 13, 2007 Female patient from JAPAN , 75 years of age, was diagnosed with open angle glaucoma and was treated with Rescula (View Usage). After Rescula was administered, patient had the following side effects: hypopyon, pemphigoid, symblepharon, ulcerative keratitis. Rescula dosage: 4 Drops Topical Ophthalmic Instillation. During the same period patient was treated with SANPILO (PILOCARPINE HYDROCHLORIDE) (8 Drops Topical Ophthalmic Instillation) (View Sanpilo (pilocarpine Hydrochloride) Review and Sanpilo (pilocarpine Hydrochloride) Label ), PIVALEPHRINE (DIPIVEFRIN HYDROCHLORIDE) (8 Drops Topical Ophthalmic Instillation) (View Pivalephrine (dipivefrin Hydrochloride) Review and Pivalephrine (dipivefrin Hydrochloride) Label ), BETOPTIC OPHTHALMIC SOLUTION (BETAXOLOL HYDROCHLORIDE) (4 Drops Topical Ophthalmic Solution) (View Betoptic Ophthalmic Solution (betaxolol Hydrochloride) Review and Betoptic Ophthalmic Solution (betaxolol Hydrochloride) Label ), HYALEIN OPHTHALMIC SOLUTION (SODIUM HYALURONATE) (View Hyalein Ophthalmic Solution (sodium Hyaluronate) Review and Hyalein Ophthalmic Solution (sodium Hyaluronate) Label ). Patient was hospitalized and became disabled.

5298157-6 | Conjunctival Disorder, Corneal Opacity, Corneal Operation, Hypopyon, Pemphigoid, Symblepharon, Ulcerative Keratitis
Patient was taking Rescula (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival disorder, corneal opacity, corneal operation, hypopyon, pemphigoid, symblepharon, ulcerative keratitis on Apr 04, 2007 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with open angle glaucoma, punctate keratitis and. Rescula dosage: 4 Drops. During the same period patient was treated with SANPILO (8 Drops) (View Sanpilo Review and Sanpilo Label ), PIVALEPHRINE (8 Drops) (View Pivalephrine Review and Pivalephrine Label ), BETOPTIC (4 Drops) (View Betoptic Review and Betoptic Label ), HYALEIN (16 Drops) (View Hyalein Review and Hyalein Label ). Patient was hospitalized and became disabled.

5293590-0 | Pemphigoid, Ulcerative Keratitis
Adverse event was reported on Feb 04, 2007 by a Female patient taking Rescula (View Usage) (Dosage: 4 Drops; Topical Ophthalmic Instillation) was diagnosed with open angle glaucoma and. Location: JAPAN , 75 years of age, Patient had the following side effects: pemphigoid, ulcerative keratitis. During the same period patient was treated with SANPILO (PILOCARPINE HYDROCHLORIDE) (8 Drops, Topical Ophthalmic Instillation) (View Sanpilo (pilocarpine Hydrochloride) Review and Sanpilo (pilocarpine Hydrochloride) Label ), PIVALEPHRINE (DIPIVEFRIN HYDROCHLORIDE) (8 Drops, Topical Ophthalmic Instillation) (View Pivalephrine (dipivefrin Hydrochloride) Review and Pivalephrine (dipivefrin Hydrochloride) Label ), BETOPTIC OPHTHALMIC SOLUTION (BETAXOLOL HYDROCHLORIDE) (4 Drops, Topical Ophthalmic Instillation) (View Betoptic Ophthalmic Solution (betaxolol Hydrochloride) Review and Betoptic Ophthalmic Solution (betaxolol Hydrochloride) Label ), HYALEIN OPHTHALMIC SOLUTION (SODIUM HYALURONATE) (View Hyalein Ophthalmic Solution (sodium Hyaluronate) Review and Hyalein Ophthalmic Solution (sodium Hyaluronate) Label ). Patient was hospitalized and became disabled.

5289289-7 | Conjunctival Disorder, Corneal Opacity, Corneal Operation, Hypopyon, Pemphigoid, Symblepharon, Ulcerative Keratitis
on Mar 22, 2007 Female patient from JAPAN , 75 years of age, was diagnosed with glaucoma (What is glaucoma?), punctate keratitis and was treated with Rescula (View Usage). After Rescula was administered, patient had the following side effects: conjunctival disorder, corneal opacity, corneal operation, hypopyon, pemphigoid, symblepharon, ulcerative keratitis. Rescula dosage: 4 Drops. During the same period patient was treated with SANPILO (8 Drops) (View Sanpilo Review and Sanpilo Label ), PIVALEPHRINE (8 Drops) (View Pivalephrine Review and Pivalephrine Label ), BETOPTIC (4 Drops) (View Betoptic Review and Betoptic Label ), HYALEIN (16 Drops) (View Hyalein Review and Hyalein Label ). Patient was hospitalized and became disabled.

5282634-8 | Conjunctival Disorder, Corneal Neovascularisation, Corneal Opacity, Eye Disorder, Hypopyon, Pemphigoid, Symblepharon, Ulcerative Keratitis
on Mar 16, 2007 Female patient from JAPAN , 75 years of age, was diagnosed with glaucoma (What is glaucoma?), punctate keratitis and was treated with Rescula (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival disorder, corneal neovascularisation, corneal opacity, eye disorder, hypopyon, pemphigoid, symblepharon, ulcerative keratitis. Rescula dosage: 4 Drops. During the same period patient was treated with SANPILO (PILOCARPINE HYDROCHLORIDE) (8 Drops) (View Sanpilo (pilocarpine Hydrochloride) Review and Sanpilo (pilocarpine Hydrochloride) Label ), PIVALEPHRINE (DIPIVEFRIN HYDROCHLORIDE) (8 Drops) (View Pivalephrine (dipivefrin Hydrochloride) Review and Pivalephrine (dipivefrin Hydrochloride) Label ), BETOPIC OPHTHALMIC SOLUTION (BETAXOLOL HYDROCHLORIDE) (4 Drops) (View Betopic Ophthalmic Solution (betaxolol Hydrochloride) Review and Betopic Ophthalmic Solution (betaxolol Hydrochloride) Label ), HYALEIN OPHTHALMIC SOLUTION (SODIUM HYALURONATE) (16 Drops) (View Hyalein Ophthalmic Solution (sodium Hyaluronate) Review and Hyalein Ophthalmic Solution (sodium Hyaluronate) Label ).

5272112-4 | Macular Oedema, Visual Acuity Reduced
Patient was taking Rescula (View Usage). Patient had the following side effects: macular oedema, visual acuity reduced on Mar 07, 2007 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with ocular hypertension and. Rescula dosage: 4 Drp, Unk. During the same period patient was treated with SANCOBA (8 Unk, Unk) (View Sancoba Review and Sancoba Label ), HYALEIN (8-12 Drps, Unk) (View Hyalein Review and Hyalein Label ), LENDORMIN (0.5 Mg, Unk) (View Lendormin Review and Lendormin Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ).

5236753-2 | Corneal Erosion, Corneal Oedema, Foreign Body Sensation In Eyes, Keratitis, Lacrimation Increased, Visual Acuity Reduced
Adverse event was reported on Jan 31, 2007 by a Male patient taking Rescula (View Usage) (Dosage: 4 Drp, Unk) was diagnosed with glaucoma (What is glaucoma?) and. Location: JAPAN , 65 years of age, After Rescula was administered, patient had the following side effects: corneal erosion, corneal oedema, foreign body sensation in eyes, keratitis, lacrimation increased, visual acuity reduced. During the same period patient was treated with SANCOBA (8 Drp, Unk) (View Sancoba Review and Sancoba Label ).

5199702-1 | Macular Oedema, Visual Acuity Reduced
on Dec 28, 2006 Female patient from JAPAN , 70 years of age, was diagnosed with ocular hypertension and was treated with Rescula (View Usage). Patient experienced the following unwanted or unexpected effects: macular oedema, visual acuity reduced. Rescula dosage: 4 Drp, Unk. During the same period patient was treated with SANCOBA (8 Unk, Unk) (View Sancoba Review and Sancoba Label ), HYALEIN (8-12 Drps, Unk) (View Hyalein Review and Hyalein Label ), LENDORMIN (0.5 Mg, Unk) (View Lendormin Review and Lendormin Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ).

4958179-9 | Eye Pain, Keratitis, Lacrimation Increased, Ulcerative Keratitis, Vision Blurred
on Mar 17, 2006 Male patient from JAPAN , 50 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Rescula (View Usage). Patient had the following side effects: eye pain, keratitis, lacrimation increased, ulcerative keratitis, vision blurred. Rescula dosage: 4 Drps/day. During the same period patient was treated with TIMOPTOL XE (View Timoptol-xe Review and Timoptol-xe Label ).

4932069-X | Conjunctivitis, Ulcerative Keratitis
Patient was taking Rescula (View Usage). After Rescula was administered, patient had the following side effects: conjunctivitis, ulcerative keratitis on Feb 22, 2006 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Rescula dosage: 4 Drp/day. During the same period patient was treated with TARIVID OPHTHALMIC (View Tarivid Ophthalmic Review and Tarivid Ophthalmic Label ).